Issue

Federal Register Volume 89 Issue 81 (Thursday, April 25, 2024)

This issue includes canonical document pages and full document metadata.

Health and Human Services Department

  1. Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers; Revised Draft Guidance for Industry; AvailabilityNotice ยท 89 FR 31757